Login / Signup

Evaluation of sclerotherapy of benign oral vascular lesions with monoethanolamine oleate.

Caio César da Silva BarrosCarolina Maria CamposHianne Cristinne de Morais MedeirosLélia Maria Guedes QueirozÉricka Janine Dantas da Silveira
Published in: Clinical oral investigations (2020)
As it is a non-invasive therapy leading, in most cases, to adequate clinical results, safety, and tolerability, sclerotherapy with MEO can be considered an effective treatment for BOVL.
Keyphrases
  • open label
  • randomized controlled trial
  • stem cells
  • clinical trial
  • replacement therapy